Copyright
©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 106197
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106197
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106197
Figure 1 Knockdown of NOTCH1 inhibits the proliferation and migration of TNBC cells in vitro.
A: After viral transduction of MDA-MB-231 cells, successfully transduced cells exhibited green fluorescence under fluorescence microscopy; B and C: RT-PCR and western blotting validation of the knockdown efficiency of NOTCH1 in stable MDA-MB-231 cells; D: CCK-8 assay results show that the proliferation of stable NOTCH1-knockdown MDA-MB-231 cells is reduced compared to wild-type MDA-MB-231 cells; E: Colony formation assay showing that colony formation of stable NOTCH1-knockdown MDA-MB-231 cells was reduced compared to wild-type MDA-MB-231 cells; F: Transwell assay showing that the invasion of stable NOTCH1-knockdown MDA-MB-231 cells was reduced compared to wild-type MDA-MB-231 cells; G: Immunofluorescence showing that after NOTCH1 knockdown, the filamentous arrangement of F-actin in MDA-MB-231 cells was suppressed, and the lamellipodia-like protrusions around the cell periphery were reduced. aP < 0.001.
- Citation: Chen WJ, Wu HT, Lan YZ, Wu Z, Yu XN, Lin WT, Liu J. NOTCH1 combined with chemotherapy synergistically inhibits triple-negative breast cancer. World J Clin Oncol 2025; 16(6): 106197
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/106197.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.106197